Join us on Rare Disease Day, February 29th, for a Twitter chat about NET (neuroendocrine tumor) cancers with Steven K. Libutti, MD, Director of Montefiore Einstein Center for Cancer Carein New York. The chat will begin at 2 pm, Eastern Time.
Follow @MontefioreNews and use the hashtag #Monte_NETs. The Carcinoid Cancer Foundation, @CarcinoidNETs, and the Carcinoid Cancer Awareness Network, @Carcinoidaware, will be the moderators for the chat. This is a terrific opportunity to ask questions and participate in a discussion about carcinoid and neuroendocrine tumors.
Dr. Libutti is one of the pioneers of regional and targeted cancer therapy as well as an internationally recognized surgical oncologist and endocrine surgeon. Prior to joining the staff at Montefiore, Dr. Libutti was senior investigator and chief of the Tumor Angiogenesis Section at the National Cancer Institute (NCI) in Maryland. His research at NCI focused on the formation of new blood vessels, which nourish tumors, as well as the interaction among tumor cells, endothelial cells, and components of the tumor microenvironment that influence tumor growth and spread. Dr. Libutti’s clinical expertise is in the management of malignancies of the liver, pancreas, and GI tract, and in applying laparoscopic surgery to managing patients with malignancies. He also provides surgical consultation and treatment for patients with disorders of the thyroid, parathyroid, and adrenal glands.